戻る
Healios K.K. (HLOSF)価格
HLOSF 株価推移チャート
HLOSF 収入
Healios K.K.
$2.1
8.8%
$0.17
終値： Jan 16, 16:00:00 GMT-5
$2.1
0%
$0
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$1.93
始値
$2.1
当日レンジ
$2.1 - $2.1
52週レンジ
$0.96 - $4.45
取引高
200
平均取引高
150
1株当たり利益(TTM)
-0.39
配当利回り
--
時価総額
$242.3M
HEALIOS K Kとは何ですか？
Healios KK engages in the research, development, and sale of cellular and regenerative medicine. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 65 full-time employees. The company went IPO on 2015-06-16. The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.